Consult Super-Specialist Doctors at CARE Hospitals
Sunitinib, a powerful drug, has made waves in the medical world for its ability to fight kidney cancer and other severe conditions. This medicine inhibits cancer cells from growing and spreading, giving hope to many people facing tough diagnoses.
Sunitinib comes in tablet form, and doctors use it for several reasons. It is not just for kidney cancer - it can also help with lung cancer and other rare tumours. This article will examine sunitinib, how to take it, and what side effects to watch out for.
Sunitinib is a potent anti-cancer medication that has an impact on multiple types of tumours. It belongs to a category called kinase inhibitors and blocks the action of abnormal proteins that signal cancer cells to multiply. This medication significantly influences stopping or slowing the cancer cells' spread and may help shrink tumours.
Sunitinib has a significant impact on treating various types of cancer, such as:
Sunitinib can cause a range of side effects, some of which may be severe. Common side effects include:
Monitoring blood pressure regularly and reporting symptoms like severe headaches or dizziness to your doctor is essential.
More severe adverse effects can occur, such as:
Taking sunitinib requires careful attention to several precautions, such as:
Sunitinib is a potent multitargeted tyrosine kinase inhibitor that impacts tumour growth and blood vessel formation. It works by blocking several proteins that signal cancer cells to multiply & form new blood vessels. This medication has a significant influence on stopping the growth of tumours and may help to shrink them.
The drug targets essential receptors involved in cancer growth, such as Vascular Endothelial Growth Factor Receptors (VEGFR) and platelet-derived growth factor receptors (PDGFR). By inhibiting these receptors, sunitinib slows down the growth of cancer cells and cuts off their blood supply, which is vital for their survival.
Sunitinib interacts with many other medications, so telling your doctor about all the ongoing medicines is essential. Some common medications that may interact with sunitinib include:
The recommended dosage of sunitinib varies depending on the condition being treated.
For gastrointestinal stromal tumours (GIST) and advanced renal cell carcinoma (RCC), doctors prescribe 50 milligrams once daily for four weeks, followed by a 2-week break. This 6-week cycle is repeated until the disease progresses or side effects become unmanageable.
The usual sunitinib dose for pancreatic neuroendocrine tumours (pNET) is 37.5 mg taken daily without breaks.
Your oncologist might adjust your dose based on how well you tolerate the medicine and its effectiveness.
Sunitinib significantly influences the treatment of various cancers, offering hope to patients facing tough diagnoses. It restricts cancer cells from growing and spreading, targeting specific proteins that are key to tumour development. This medication has shown effectiveness in treating kidney cancer, gastrointestinal stromal tumours, and pancreatic neuroendocrine tumours, making it a versatile tool in the fight against cancer.
Sunitinib has an impact on treating various types of cancer, including advanced renal cell carcinoma, gastrointestinal stromal tumours, and pancreatic neuroendocrine tumours. It stops the growth and spread of cancer cells and may help to shrink tumours. Sunitinib tablets are used when other treatments have not been effective or cannot be taken.
Sunitinib is taken once daily, with or without food.
Sunitinib belongs to the tyrosine kinase inhibitors drug family. Other drugs in this class include sorafenib and pazopanib. These medications work similarly by blocking specific proteins that signal cancer cells to multiply. However, each drug may have different uses and side effects.
The duration of sunitinib treatment depends on how well it works and how well you tolerate it. Some patients may take sunitinib for extended periods, even years, if it continues to be effective and side effects are manageable. Your doctor will monitor your prognosis and adjust the treatment as needed.
Sunitinib has shown significant effectiveness in treating certain cancers. In clinical trials, it has demonstrated improved progression-free survival & overall survival rates in patients with advanced renal cell carcinoma. The response rates vary depending on the type of cancer and individual factors.
The duration of sunitinib's effectiveness varies among patients. Some may experience benefits for several months or even years, while others might have a shorter response time. Regular monitoring and scans help determine how long the drug continues to work. If the cancer progresses, your doctor may consider alternative treatments.
Sunitinib can have an impact on kidney function. Some patients may experience proteinuria (protein in urine) or changes in kidney function. Regular monitoring of kidney function and urine tests are essential during treatment. If significant kidney problems occur, your doctor may adjust the dose or consider alternative therapies.
The dosing for sunitinib varies depending on the type of cancer. For kidney cancer and gastrointestinal stromal tumours, the typical dose is 50 mg daily for four weeks, followed by a 2-week break. For pancreatic neuroendocrine tumours, it is usually 37.5 mg daily without breaks.
If surgery is advised, your doctor will likely advise you to stop taking sunitinib at least three weeks before the procedure. This is because sunitinib can affect wound healing. Your doctor will give you instructions on when to stop and when you can safely restart the medication after surgery.